|
US2612503A
(en)
|
1949-04-19 |
1952-09-30 |
Smith Kline French Lab |
Basic ether-substituted isoquinolines
|
|
US2538341A
(en)
|
1949-09-20 |
1951-01-16 |
Smith Kline French Lab |
Method for producing 1-hydroxyisoquinolines
|
|
US3404157A
(en)
|
1965-02-24 |
1968-10-01 |
American Cyanamid Co |
Substituted pyrroloindazole compounds
|
|
US4198415A
(en)
|
1979-01-22 |
1980-04-15 |
Eli Lilly And Company |
Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
|
|
US4647667A
(en)
|
1982-11-03 |
1987-03-03 |
Eli Lilly And Company |
Octa- and deca-hydroquinoline intermediates
|
|
US4778894A
(en)
|
1983-09-26 |
1988-10-18 |
Eli Lilly And Company |
6 oxo-decahydroquinolines
|
|
US5358949A
(en)
|
1986-03-05 |
1994-10-25 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
|
|
DK158590D0
(da)
|
1990-07-02 |
1990-07-02 |
Lundbeck & Co As H |
Indolderivater
|
|
JPH11501004A
(ja)
|
1995-02-01 |
1999-01-26 |
ユニヴァーシティー・カレッジ・カーディフ・コンサルタンツ・リミテッド |
三環系誘導体及びそれらの抗ガン剤としての使用
|
|
US5639780A
(en)
|
1995-05-22 |
1997-06-17 |
Merck Frosst Canada, Inc. |
N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
|
|
JP2000072751A
(ja)
|
1998-08-26 |
2000-03-07 |
Tanabe Seiyaku Co Ltd |
イソキノリノン誘導体
|
|
JP2000281654A
(ja)
|
1999-03-26 |
2000-10-10 |
Tanabe Seiyaku Co Ltd |
イソキノリン誘導体
|
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
|
FR2802532A1
(fr)
|
1999-12-17 |
2001-06-22 |
Sanofi Synthelabo |
Derives de 2-phenyl-quinoleine, leur preparation et leur application en therapeutique
|
|
DK1242382T3
(da)
|
1999-12-29 |
2007-05-07 |
Wyeth Corp |
Tricycliske proteinkinaseinhibitorer
|
|
US6638929B2
(en)
|
1999-12-29 |
2003-10-28 |
Wyeth |
Tricyclic protein kinase inhibitors
|
|
EP1305308B1
(en)
|
2000-07-26 |
2006-12-20 |
Smithkline Beecham Plc |
Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
|
|
AU2002211901A1
(en)
|
2000-10-10 |
2002-04-22 |
Smithkline Beecham Corporation |
Substituted indoles, pharmaceutical compositions containing such indoles and their use as PPAR-gamma binding agents
|
|
US6906192B2
(en)
|
2000-11-07 |
2005-06-14 |
Bristol Myers Squibb Company |
Processes for the preparation of acid derivatives useful as serine protease inhibitors
|
|
US20030212085A1
(en)
|
2001-04-17 |
2003-11-13 |
Mccall Robert B. |
Treatment of fibromyalgia and chronic fatigue syndrome
|
|
EP1396488A1
(en)
|
2001-05-23 |
2004-03-10 |
Mitsubishi Pharma Corporation |
Fused heterocyclic compound and medicinal use thereof
|
|
US6706423B2
(en)
|
2001-12-27 |
2004-03-16 |
Lightronik Technology Inc. |
Organic EL device
|
|
TW200400963A
(en)
*
|
2002-05-21 |
2004-01-16 |
Wyeth Corp |
R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
|
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
WO2004108120A1
(en)
|
2003-06-11 |
2004-12-16 |
Pfizer Products Inc. |
Use of growth hormone secretagogues for treatment of fibromyalgia
|
|
BRPI0412820A
(pt)
|
2003-07-25 |
2006-09-26 |
Pfizer |
compostos de aminopirazol e utilização como inibidores de chk1
|
|
US7208601B2
(en)
|
2003-08-08 |
2007-04-24 |
Mjalli Adnan M M |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
US7723352B2
(en)
|
2003-09-23 |
2010-05-25 |
Merck Sharp & Dohme |
Isoquinolinone potassium channel inhibitors
|
|
WO2006019831A1
(en)
|
2004-07-14 |
2006-02-23 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
US8097644B2
(en)
|
2006-03-28 |
2012-01-17 |
Allergan, Inc. |
Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist
|
|
BRPI0710527B8
(pt)
|
2006-04-04 |
2021-05-25 |
Fibrogen Inc |
compostos de pirrolo- e tiazolo-piridina e composição farmacêutica que os compreende
|
|
DK2013619T3
(en)
|
2006-04-10 |
2017-12-04 |
Wisconsin Alumni Res Found |
METHODS FOR USING HUMAN EMBYO STEM CELLS FOR EVALUATION OF THE PHARMACEUTICAL SUBSTANCE AND OTHER CHEMICALS
|
|
TW200813054A
(en)
|
2006-06-02 |
2008-03-16 |
Elan Pharm Inc |
Fused, tricyclic sulfonamide inhibitors of gamma secretase
|
|
SG176477A1
(en)
|
2006-08-07 |
2011-12-29 |
Ironwood Pharmaceuticals Inc |
Indole compounds
|
|
WO2008143633A2
(en)
|
2007-01-10 |
2008-11-27 |
University Of Florida |
Compounds and methods for treatment of alpha-1 antitrypsin deficiency
|
|
US20100016285A1
(en)
|
2007-01-24 |
2010-01-21 |
Mochida Pharmaceutical Co., Ltd. |
Heterocyclidene-n-(aryl) acetamide derivative
|
|
JP5107589B2
(ja)
|
2007-02-13 |
2012-12-26 |
旭化成株式会社 |
インドール誘導体
|
|
RU2337915C1
(ru)
|
2007-03-14 |
2008-11-10 |
Общество с ограниченной ответственностью "Инжиниринговая компания "ИНКОМП-НЕФТЬ" |
Комплексонат нитрилотри(метиленфосфонато)-2-фенил-3-этил-8-оксихинолин натриевая соль в качестве ингибитора солеотложений
|
|
GB0722055D0
(en)
|
2007-11-09 |
2007-12-19 |
Argenta Discovery Ltd |
Compounds
|
|
DE102008022521A1
(de)
|
2008-05-07 |
2009-11-12 |
Bayer Schering Pharma Aktiengesellschaft |
1,4-Diaryl-pyrimidopyridazin-2,5-dione und ihre Verwendung
|
|
JP4856667B2
(ja)
|
2008-03-27 |
2012-01-18 |
ジヤトコ株式会社 |
自動変速機における回転軸の支持構造
|
|
HUE025471T2
(hu)
|
2008-04-16 |
2016-03-29 |
Karobio Ab |
Új ösztrogén receptor ligandumok
|
|
WO2009158587A1
(en)
|
2008-06-26 |
2009-12-30 |
Inspire Pharmaceuticals, Inc. |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
|
WO2011056222A1
(en)
|
2009-11-05 |
2011-05-12 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods of treating disorders associated with protein aggregation
|
|
WO2011110852A1
(en)
|
2010-03-10 |
2011-09-15 |
Astrazeneca Ab |
Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
|
|
EP2566869B1
(en)
|
2010-05-07 |
2016-03-02 |
Gilead Connecticut, Inc. |
Pyridone and aza-pyridone compounds and methods of use
|
|
AU2011287952B2
(en)
*
|
2010-08-04 |
2014-08-21 |
Grünenthal GmbH |
Pharmaceutical dosage form comprising 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane- 1,1'-pyrano[3,4,b]indol]-4-amine
|
|
KR101753447B1
(ko)
|
2010-09-24 |
2017-07-03 |
그리폴스 테라퓨틱스 인코포레이티드 |
면역크로마토그래피 장치, 방법 및 키트
|
|
US20130167932A1
(en)
|
2010-11-08 |
2013-07-04 |
Nec Corporation |
Indole compound, and photoelectric conversion dye using same, semiconductor electrode, photoelectric conversion element, and photoelectrochemical cell
|
|
JPWO2012111610A1
(ja)
|
2011-02-14 |
2014-07-07 |
日本電気株式会社 |
チアゾール系化合物及びその用途
|
|
WO2012178102A2
(en)
|
2011-06-24 |
2012-12-27 |
The Regents Of The Unversity Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
CN103239451A
(zh)
|
2012-02-10 |
2013-08-14 |
上海医学生命科学研究中心有限公司 |
吡咯并喹啉醌在治疗和/或预防肝纤维化中的应用
|
|
US20140135359A1
(en)
|
2012-11-12 |
2014-05-15 |
Louis C. Martineau |
Methods of designing, preparing, and using novel protonophores
|
|
AP2016008970A0
(en)
|
2013-07-10 |
2016-01-31 |
Bayer Pharma AG |
Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof
|
|
US9572794B2
(en)
|
2014-08-06 |
2017-02-21 |
Vanderbilt University |
Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists
|
|
WO2016154051A1
(en)
|
2015-03-20 |
2016-09-29 |
University Of Florida Research Foundation, Inc. |
Combination therapy for treating infections diseases
|
|
WO2017035418A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Disubstituted compounds for treatment of immune and inflammatory disorders
|
|
JP7046814B2
(ja)
|
2015-12-30 |
2022-04-04 |
ジェネンテック， インコーポレイテッド |
タンパク質製剤のためのトリプトファン誘導体の使用
|
|
ES2910787T3
(es)
|
2016-05-12 |
2022-05-13 |
Univ Michigan Regents |
Inhibidores de ASH1L y métodos de tratamiento con los mismos
|
|
CA3024522C
(en)
|
2016-05-31 |
2024-06-25 |
Polyphor Ag |
Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof
|
|
CA3047336A1
(en)
|
2017-01-23 |
2018-07-26 |
Jecure Therapeutics, Inc. |
Chemical compounds as inhibitors of interleukin-1 activity
|
|
UY37581A
(es)
|
2017-02-02 |
2018-08-31 |
Gilead Sciences Inc |
Compuestos para el tratamiento de la infección por virus de la hepatitis b
|
|
EP3630109A4
(en)
|
2017-05-26 |
2021-03-17 |
Rutgers, the State University of New Jersey |
BACTERIAL EFFLUX PUMP INHIBITORS
|
|
US20200247815A1
(en)
|
2017-10-19 |
2020-08-06 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Pyrazolyl-containing tricyclic derivative, preparation method therefor and use thereof
|
|
PE20201170A1
(es)
|
2017-11-01 |
2020-10-28 |
Bristol Myers Squibb Co |
Compuestos biciclicos en puente como moduladores del receptor farnesoide x
|
|
CN107698505A
(zh)
|
2017-11-20 |
2018-02-16 |
孙婷婷 |
一种诺得司他的制备方法
|
|
SMT202200396T1
(it)
|
2017-12-13 |
2022-11-18 |
Lupin Ltd |
Composti eterociclici biciclici sostituiti come inibitori di prmt5
|
|
CN111971278B
(zh)
|
2018-01-31 |
2023-08-11 |
默克专利有限公司 |
用作irak抑制剂的喹啉化合物及其用途
|
|
MX2020013853A
(es)
*
|
2018-06-22 |
2021-05-27 |
Ucl Business Ltd |
Compuestos innovadores.
|
|
TWI748194B
(zh)
|
2018-06-28 |
2021-12-01 |
德商菲尼克斯 Ｆｘｒ有限責任公司 |
含有雙環核心部分之新穎lxr調節劑
|
|
US12173026B2
(en)
|
2018-08-07 |
2024-12-24 |
Merck Sharp & Dohme Llc |
PRMT5 inhibitors
|
|
EP3620164A1
(en)
|
2018-09-05 |
2020-03-11 |
Genoscience Pharma SAS |
Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins b (ctsb), l (ctsl) and d (ctsd) related diseases
|
|
CA3114672A1
(en)
|
2018-10-05 |
2020-04-23 |
Vertex Pharmaceuticals Incorporated |
Modulators of alpha-1 antitrypsin
|
|
CN110776459B
(zh)
|
2019-03-19 |
2023-01-24 |
江苏知原药业股份有限公司 |
7-羟基-2-喹诺酮-二硫代氨基甲酸酯类胆碱酯酶抑制剂
|
|
US11884672B2
(en)
|
2019-05-14 |
2024-01-30 |
Vertex Pharmaceuticals Incorporated |
Modulators of alpha-1 antitrypsin
|
|
TW202116303A
(zh)
|
2019-10-02 |
2021-05-01 |
美商維泰克斯製藥公司 |
α—１抗胰蛋白酶缺乏症之治療方法
|
|
BR112022014861A2
(pt)
|
2020-01-30 |
2022-09-20 |
Vertex Pharma |
Métodos de tratamento para deficiência de alfa-1 antittripsina
|
|
CN115697969A
(zh)
|
2020-04-03 |
2023-02-03 |
弗特克斯药品有限公司 |
作为用于治疗α-1抗胰蛋白酶缺乏症(AATD)的α-1抗胰蛋白酶调节剂的7-或8-羟基-异喹啉和7-或8-羟基-喹啉衍生物
|
|
IL296920A
(en)
*
|
2020-04-03 |
2022-12-01 |
Vertex Pharma |
Indole derivatives as alpha-1-antitrypsin modulators for the treatment of alpha-1-antitrypsin deficiency (aatd)
|
|
WO2021203025A1
(en)
|
2020-04-03 |
2021-10-07 |
Vertex Pharmaceuticals Incorporated |
1 h-pyrazolo[4,3-g]isoquinoline and 1 h-pyrazolo[4,3-g]quinoline derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd)
|
|
JP7732999B2
(ja)
|
2020-04-03 |
2025-09-02 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
アルファ１－アンチトリプシンのモジュレーター
|
|
CN115776984A
(zh)
|
2020-04-03 |
2023-03-10 |
弗特克斯药品有限公司 |
作为用于治疗α-1抗胰蛋白酶缺乏症(AATD)的α-1-抗胰蛋白酶调节剂的吡咯并[2,3-f]吲唑和2,4,5,10-四氮杂三环[7.3.0.03,7]十二碳-1,3(7),5,8,11-五烯衍生物
|
|
AU2021246104A1
(en)
|
2020-04-03 |
2022-10-20 |
Vertex Pharmaceuticals Incorporated |
Modulators of alpha-1 antitrypsin
|
|
WO2022026372A2
(en)
|
2020-07-27 |
2022-02-03 |
Vertex Pharmaceuticals Incorporated |
Processes for preparing modulators of alpha-1 antitrypsin
|
|
WO2022104353A1
(en)
|
2020-11-12 |
2022-05-19 |
Vertex Pharmaceuticals Incorporated |
Methods of monitoring alpha-1 antitrypsin (aat) deficiency by measuring polymerised aat
|
|
AU2021381509A1
(en)
|
2020-11-17 |
2023-06-22 |
Vertex Pharmaceuticals Incorporated |
Solid forms of 4-(5-(4-fluorophenyl)-6-tetrahydro-2h-pyran-4-yl)- 1,5-dihydropyrrolo[2,3-f]indazol-7-yl)benzoic acid
|
|
PE20251573A1
(es)
|
2022-09-09 |
2025-06-12 |
Vertex Pharma |
Moduladores de la alfa-1 antitripsina
|